Clinical Study
Sentinel Lymph Node Biopsy in Pure DCIS: Is It Necessary?
Table 2
Multivariate analyses for predictive factors associated with the presence of SLNB in patients with pure DCIS.
| Factors | Odds ratio (95% CI) | value |
| Nuclear grade intermediate and high (versus low) | 8.1 (1.4–48.2) | 0.021 | Tumor size >30 mm (versus ≤30 mm) | 5.5 (0.9–31.6) | 0.059 | Mastectomy (versus breast conservation) | 14 (2.3–84.3) | 0.004 | Palpable mass (versus nonpalpable) | 3.5 (0.6–21.6) | 0.186 |
|
|